Subcutaneous Versus Intravenous Tocilizumab in Aortitis Associated With Giant Cell Arteritis: Multicenter Study of 196 Patients
In this real-world cohort of GCA-associated aortitis, SC TCZ showed slightly greater effectiveness than IV TCZ in achieving EULAR-defined remission, whereas no significant differences were observed between both routes regarding imaging remission.
Authors
- A. Martínez Gutiérrez
- J Narvaez
- Vicente Aldasoro
- E. de Miguel
- Paloma Ayala Vela
- Jesús Carlos Fernández‐López
- Santos Castañeda
- Ricardo Blanco
- Cristina Campos
- Olga Maiz
- Eva Galíndez‐Agirregoikoa
- Julio Sanchez‐Martín
- Patricia Moya
- The Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group
- Iván Ferraz‐Amaro
- Susana Romero‐Yuste
- Javier Loricera
- Carmen Secada‐Gómez
Institutions
- Hospital Universitario de Canarias (ES)
- Hospital Universitario La Paz (ES)
- Hospital de Sant Pau (ES)
- Bellvitge University Hospital (ES)
- Hospital San Juan de la Cruz (ES)
- Hospital de Basurto (ES)
- Complejo Hospitalario de Navarra (ES)
- Marqués de Valdecilla University Hospital (ES)
- Biogipuzkoa Health Research Institute (ES)
- Hospital Universitario 12 De Octubre (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Hospital General Universitario De Valencia (ES)
- Hospital Universitario de La Princesa (ES)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
- Donostiako Unibertsitate Ospitalea (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Complejo Hospitalario de Pontevedra (ES)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1002/acr.80006
- Citations
- 1
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 36.44